We are a Biotech-startup focused on developing novel genetic therapies.
Our goal is to develop novel therapies that target only cells causing a disease, with minimal patient burden.
We create the future where our therapies allow patients to live healthier and more fulfilling lives.
We believe our ingenuity and curiosity can lead us to the future.
Related link: Press release
aceRNA Technologies has raised funds from Nitto Denko and Mitsubishi UFJ Capital. aceRNA will use this capital to develop “smart gene therapy” (mRNA-based and virus-base) that enables
control of therapeutic transgene expression in cell-type and -state specific manner.
Related link (in Japanese)：https://www.jetro.go.jp/news/releases/2021/af727f3ff68fbc5e.html